Evidence map›Paper›PMID 32338409›Full record

ArticleCancer science2020

Cancer stem cells in Epstein-Barr virus-associated gastric carcinoma.

Mariko Yasui, Akiko Kunita, Satoe Numakura, Hiroshi Uozaki, Tetsuo Ushiku, Masashi Fukayama

Open access · goldAbstract read
In one paragraph

Article in Cancer science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Alteration in stemness causes exclusivity between Epstein-Barr virus-positivity and microsatellite instability status in gastric cancer.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2021
    Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Mariko YasuiDepartment Pathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Akiko KunitaDepartment Pathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Satoe NumakuraDepartment Pathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Hiroshi UozakiDepartment Pathology, Teikyo University School of Medicine, Tokyo, Japan.
Tetsuo UshikuDepartment Pathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Masashi FukayamaDepartment Pathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.ORCID https://orcid.org/0000-0002-0460-064X
The University of Tokyo · JPAsahi General Hospital · JPTeikyo University · JP

Funding

Japan Science and Technology AgencyJapan Society for the Promotion of Science 26253021the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research/26253021
6 · The paper itself

Abstract

Cancer stem cells (CSCs) play a decisive role in the development and progression of cancer. To investigate CSCs in Epstein-Barr virus (EBV)-associated carcinoma (EBVaGC), we screened previously reported stem cell markers of gastric cancer in EBV-infected gastric cancer cell lines (TMK1 and NUGC3) and identified CD44v6v9 double positive cells as candidate CSCs. CD44v6/v9

Indexed as

AnimalsBiomarkersCell Line, TumorDisease Models, AnimalEpstein-Barr Virus InfectionsHerpesvirus 4, HumanHumansImmunophenotypingMiceNeoplastic Stem CellsNF-kappa BSignal TransductionStomach NeoplasmsXenograft Model Antitumor AssaysBiomarkersNF-kappa BcarcinomaEpstein-Barr virus infectionneoplastic stem cellsignal transductionstomach neoplasm

Identifiers

PMID32338409
PMCPMC7385383
OpenAlexW3017640110

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.